BIOGEN INC. R&D Expense 2007-2013 | BIIB
Beta
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is BIOGEN INC.'s current r&d expense?
BIOGEN INC. (BIIB) annual r&d expense for 2012 was $1.33B, a 9.46% increase from 2011. BIOGEN INC. r&d expense for the quarter ending March 31, 2013 was $284.3M.
What was BIOGEN INC.'s r&d expense in 2011?
BIOGEN INC. annual r&d expense for 2011 was $1.22B, a 2.32% decline from 2010.
What was BIOGEN INC.'s r&d expense in 2010?
BIOGEN INC. annual r&d expense for 2010 was $1.25B, a 2.69% decline from 2009.
What is BIOGEN INC.'s 5-year r&d expense CAGR?
BIOGEN INC. r&d expense grew at a compound annual growth rate (CAGR) of 7.61% from FY2007 to FY2012, going from $925.2M to $1.33B over 5 years.
R&D Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+7.6%
FY2007
$925.2M
→
FY2012
$1.33B
070809101112
5 years selected
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →